RGDXQ OTC
Response Genetics, Inc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -95.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$14M
+4.9% ▲
Capital Expenditures
$1M
-1000.5% ▼
5Y CAGR: +23.9%
Free Cash Flow
-$15M
-2.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
-2.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $0 | -$8M | -$8M | -$14M | -$20M |
| Depreciation & Amort. | $367K | $470K | $633K | $828K | $2M |
| Stock-Based Comp. | $724K | $818K | $474K | $862K | $3M |
| Change in Working Capital | -$2M | -$3M | -$3M | -$8M | $934K |
| Other Non-Cash Items | -$4M | $818K | $474K | $920K | $27K |
| Operating Cash Flow | -$5M | -$8M | -$6M | -$14M | -$14M |
| — Investing Activities — | |||||
| Capital Expenditures | -$391K | -$957K | -$608K | -$104K | -$1M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | -$7M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$200K | $2K | $6M |
| Investing Cash Flow | -$391K | -$957K | -$808K | -$102K | -$3M |
| — Financing Activities — | |||||
| Net Debt Issuance | $939K | -$148K | -$188K | $8M | -$83K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $10K | $0 | $0 | -$9M | -$126K |
| Financing Cash Flow | $3M | $16M | $6M | $8M | $10M |
| Net Change in Cash | -$2M | $7M | -$893K | -$6M | -$6M |
| Cash End of Period | $2M | $9M | $8M | $2M | $19M |
| Free Cash Flow | -$5M | -$9M | -$7M | -$14M | -$15M |